The Leuven experience with a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation revealed by azithromycin

European Respiratory Review

Volumn 17, Issue 108, 2008, Pages 93-95

  Vanaudenaerde, Bart ^a,b   Vos, Robin ^a   Geudens, Nele ^a   Van Raemdonck, Dirk ^a   Dupont, Lieven ^a   Verleden, Geert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Pediatric Transplant Unit   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ACUTE GRAFT REJECTION; BRONCHIOLITIS OBLITERANS; CHEMICAL ANALYSIS; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GRAFT DYSFUNCTION; HUMAN; INFECTION; INFLAMMATION; LUNG TRANSPLANTATION; MORTALITY; PREVALENCE; RISK FACTOR; SHORT SURVEY; TREATMENT RESPONSE;

EID: 45749095074     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00010813     Document Type: Short Survey

References (13)

1. Vanaudenaerde BM, Wuyts WA, Dupont LJ, Van Raemdonck DE, Demedts MM, Verleden GM. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22: 1280-1283.
2. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE, Demedts MG, Verleden GM. Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-κB. J Heart Lung Transplant 2005; 24: 875-881.
3. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE, Demedts MG, Verleden GM. N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from human airway smooth muscle cells: a possible role for anti-oxidative treatment in chronic lung rejection? J Heart Lung Transplant 2004; 23: 122-127.
4. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27: 779-787.
5. Vanaudenaerde BM, Dupont LL, Wuyts WA, Seghers S, Van Raemdonck DE, Verleden GM. IL8 and IL17 are upregulated in BAL fluid of lung tranplant patients with bronchiolis obliterans syndrome. Eur Respir J 2004; 24: Suppl. 48, 465s.
6. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003; 168: 121-125.
7. Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004; 77: 1465-1467.
8. Verleden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 2005; 25: 221-224.
9. Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and IL-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006; 174: 566-570.
10. Vanaudenaerde BM, Wuyts WA, Geudens N, et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007; 7: 76-81.
11. Vos R, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE, Verleden GM. Transient airway colonization is associated with airway inflammation after lung transplantation. Am J Transplant 2007; 7: 1278-1287.
12. Vos R, Vanaudenaerde BM, Geudens N, Dupont LJ, Van Raemdonck DE, Verleden GM. Pseudomonal airway colonisation: a risk factor for BOS after lung transplantation? Eur Respir J 2008 [Epub ahead of print PMID: 18256072].
13. Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastrooesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J 2007; 31: 707-713.